Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
76 /100
COMPONENT-LIMITED
Score updated Sep 28, 2026

ONTX — Traws Pharma, Inc. Dilution Risk Tracker

Track ONTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ONTX — Get alerts when the score changes →

As of September 28, 2026, Traws Pharma, Inc. (ONTX) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Traws Pharma, Inc. has 15.37M shares outstanding. Stored dilution-related fields include 35.51M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊Float Risk—
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 39%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 231% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration model 30%
• Score climbed 7 points (worsening)
• Score already CRITICAL (76/100) — events likely imminent
🔔 Track ONTX — Get forecast alerts →

Market Data

Market CapN/A
Shares Outstanding15.37M
FloatN/A
Cash$20.56M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore76/100DilutionWatch score record
Shares Outstanding15.37MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market CapNot availableMarket data cache
Cash Runway14.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants35.51MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest5.1K
Days to Cover1.5
% of FloatN/A
FINRA data as of Sep 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2024-12-31
Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ONTX Dilution Snapshot

Traws Pharma, Inc. (ONTX) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: September 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ONTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ONTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,439+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for ONTX
ONTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.